StockData
Camp4 Therapeutics Corp logo

Camp4 Therapeutics Corp (CAMP) stock

CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$4.10+0.10 (+2.50%)

Close on Nov 18, 2026Market cap $257.29MP/E –Yield 0.00%

Camp4 Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Camp4 Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $4.22M, up 40.2% year over year. For fiscal 2025 it was $3.50M, up 436.5% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.50M+436.5%
FY2024Dec 31, 2024$652.00K+86.3%
FY2023Dec 31, 2023$350.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.78M+18.8%
Q1 FY2026Mar 31, 2026$1.29M+50.8%
Q4 FY2025Dec 31, 2025$348.00K-46.6%
Q3 FY2025Sep 30, 2025$795.00K–
Q2 FY2025Jun 30, 2025$1.50M–
Q1 FY2025Mar 31, 2025$858.00K–
Q4 FY2024Dec 31, 2024$652.00K–
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$0–
Q1 FY2024Mar 31, 2024$0–
Q4 FY2023Dec 31, 2023$0–
Q3 FY2023Sep 30, 2023$350.00K–

More Camp4 Therapeutics figures

See a number that looks wrong?